Advertisement
Screener

EXACT SCIENCES CORP Form 8-K: Current report, 2021

EXACT SCIENCES CORP Form 8-K: Current report

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2021-11-29: Form 8-K; Period of report 2021-11-29; Description 1.01 Entry into a Material Definitive Agreement.
  • 2021-11-02: Form 8-K; Period of report 2021-11-02; Description 2.02 Results of Operations and Financial Condition.
  • 2021-09-15: Form 8-K; Period of report 2021-09-15; Description 8.01 Other Events.
  • 2021-07-28: Form 8-K; Period of report 2021-07-28; Description 2.02 Results of Operations and Financial Condition.
FiledFormPeriod of reportDescriptionDetailsDocument
2021-11-298-K2021-11-291.01 Entry into a Material Definitive Agreementexas-20211129.htm
2021-11-028-K2021-11-022.02 Results of Operations and Financial Conditionexas-20211102.htm
2021-09-158-K2021-09-158.01 Other Eventsexas-20210915.htm
2021-07-288-K2021-07-282.02 Results of Operations and Financial Conditionexas-20210728.htm
2021-07-028-K2021-06-305.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holdersexas-20210630.htm
2021-06-078-K2021-06-078.01 Other Eventsexas-20210607.htm
2021-05-048-K2021-05-042.02 Results of Operations and Financial Conditionexas-20210504.htm
2021-05-038-K2021-04-275.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officersexas-20210427.htm
2021-03-188-K2021-03-185.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officersexas-20210318.htm
2021-03-038-K2021-03-035.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year; 8.01 Other Eventsexas-20210303.htm
2021-02-168-K2021-02-162.02 Results of Operations and Financial Conditionexas-20210216.htm
2021-01-158-K2021-01-115.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers5.02 Andrew Slavitt has been appointed by President-elect Joseph R. Biden, Jr. as White House Senior Advisor for COVID Response.tm213269d1_8k.htm
2021-01-118-K2021-01-102.02 Results of Operations and Financial Condition; 7.01 Regulation FD Disclosureexas-20210110.htm
2021-01-058-K2021-01-058.01 Other Eventsexas-20210105.htm
2021-01-058-K2021-01-052.02 Results of Operations and Financial Condition; 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 7.01 Regulation FD Disclosure; 8.01 Other Events2.02 On January 5, 2021, Exact Sciences Corporation (the “Company”) provided preliminary guidance that it expects to exceed consensus fourth quarter 2020 forecasts for each of total revenue (FactSet consensus estimate $427 million), Screening revenue (FactSet consensus estimate $230 million), Precision Oncology revenue (FactSet consensus estimate $104 million), and COVID-19 testing revenue (FactSet consensus estimate $92 million).
5.02 On January 5, 2021, Mark Stenhouse departed from his position as the Company’s General Manager, Screening.
7.01 On January 5, 2021, the Company issued a press release announcing the completion of its previously announced acquisition (the “Acquisition”) of Thrive Earlier Detection Corp. (“Thrive”).
8.01 On January 5, 2021, the Company completed the Acquisition pursuant to the Agreement and Plan of Merger, dated October 26, 2020 (the “Merger Agreement”) by and among the Company, certain subsidiaries of the Company, Thrive, and Shareholder Representative Services, LLC, solely in its capacity as holders’ representative.
tm211558d1_8k.htm